Ghassan Nino
Corporate Officer/Principal bei Biogress LLC
Profil
Ghassan Nino has served as Vice Chairman of Hemobiotech, Inc. since October 6, 2003.
He founded HemoBioTech, Inc. in December 2001.
From October 6, 2003 to July 15, 2004, Mr. Nino served as Vice Chairman and Acting Chief Financial Officer of Hemobiotech.
In April 2003, he co-founded Biogress LLC and has served as its Managing Director since that time.
In April 2002, he founded Pave Systems, Inc. and has served as its Managing Director since that time.
He founded Ascend Mobility, Inc. and served as a Director until March 2004.
From 1997 to 1998, Mr. Nino was a Practice Development Director at Deloitte Touche Tohmatsu.
He received an MBA from California State, Fullerton.
Aktive Positionen von Ghassan Nino
Unternehmen | Position | Beginn |
---|---|---|
Biogress LLC | Corporate Officer/Principal | 01.04.2003 |
Pave Systems, Inc. | Corporate Officer/Principal | 01.04.2002 |
Ehemalige bekannte Positionen von Ghassan Nino
Unternehmen | Position | Ende |
---|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Gründer | 05.11.2012 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
Biogress LLC | |
Pave Systems, Inc. |